Fecal Calprotectin Testing Market Size

Fecal Calprotectin Testing Market size was valued at USD 145.44 million in 2024 and is set to reach USD 473.1 million by the end of 2037, expanding at around 10.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of fecal calprotectin testing is assessed at USD 158.24 million.

The growth of the market can be attributed to the increasing prevalence of colon rectum cancer, inflammatory bowel syndrome, and other gastrointestinal disorders, as the fecal calprotectin test is used for the diagnosis of these diseases. The recent statistics revealed by the World Health Organization stated that colon and rectum cancer was considered to be one of the most prevalent cancers across the globe, with around 1.93 million cases being diagnosed worldwide in 2020, and taking approximately 916,000 lives in the same year.

In addition to the aforementioned factors, the other factors that are expected to expand the market size are the rising cases of cancers in small and large intestines. Also, the rising prevalence of inflammatory bowel disease, celiac disease, colorectal cancer, and other problems among the global population is expected to generate a demand for fecal calprotectin testing. Also, the indulgence in unhealthy lifestyles and consumption of junk food items has propelled the development of severe gastrointestinal illnesses across the globe which is a positive indicator for a high utilization rate of fecal calprotectin testing in the upcoming years. Furthermore, the rapid growth of the healthcare industry along with the presence of technologically developed facilities including e-prescribing is anticipated to ease the process of fecal calprotectin testing.